🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
🚀 Biotech & Life Sciences – Latest Highlights 🔹 VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer 🔹 Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results 🔹 Allonnia and Eagle Mine Partner to Deploy D-Solve™ Technology to Unlock More Nickel 🔹 Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale 🔹 Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer 🔹 Ousted FDA vaccine chief Vinay Prasad is ...
BioTech Weekly
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
